Comprehensive Cardiovascular Review Notes

Electrocardiography & Arrhythmia Management

  • Standard ECG calibration: 1mV1\,mV and 200ms200\,ms (11 big box = 55 small boxes = 200ms200\,ms).
  • Wide QRS complex definition: 3\ge 3 small boxes.
  • QTc reference thresholds: Females = 460ms460\,ms; Males = 450ms450\,ms (46010ms460 - 10\,ms).
  • A 66-second ECG strip contains 150150 small boxes.
  • ECG Rhythm Identification Rules:
    • Absence of P wave + fast HR + narrow QRS + irregular rhythm = Atrial Fibrillation.

Atrial Fibrillation ECG Strip

  • Absence of P wave + fast HR + wide QRS + regular rhythm = Ventricular Tachycardia.

Ventricular Tachycardia ECG Strip

  • Narrow QRS + regular rhythm = Supraventricular Tachycardia (Initial treatment: adenosine; Alternative: verapamil).
  • Multiple discrete P wave morphologies + pulmonary disease context = Multifocal Atrial Tachycardia.
    • Atrioventricular (AV) Blocks: Constant or fixed PR interval followed by a dropped QRS complex = 2nd2nd-degree AV Block Mobitz Type II.
    • Cardiac Resuscitation Management:
  • Unconsciousness with BP = 0mmHg0\,mmHg and HR = 0bpm0\,bpm: Immediate CPR before epinephrine administration.
  • Symptomatic Junctional Bradycardia: Initial drug is Atropine (followed by Transcutaneous Pacing, Dopamine, or Epinephrine).
    • Electrophysiology: L-type Ca2+Ca^{2+} channels open during Phase 00; Funny channels operate during Phase 44.
    • Reversible causes of cardiac arrest (5Ts5Ts and 5Hs5Hs): Thrombosis can be either coronary or pulmonary.

Diseases of the Aorta & Vascular Disorders

  • Aortic Anatomy & Landmarks:
    • Arch of the aorta begins at the right brachiocephalic artery.
    • Anatomical levels: T4 (nipple line), T6 (xiphoid process), T8 (IVC aperture), T10 (esophageal hiatus), T12 (aorta hiatus - descending thoracic aorta termination), L4 (aortic bifurcation).
  • Aortic Aneurysms:
    • Saccular aneurysm: Asymmetric outpouching involving all vascular wall layers.
    • Abdominal Aortic Aneurysm (AAA): Majority originate from the infrarenal artery.
    • AAA rapid growth definition: 1cm/year1\,cm/year.
    • 55-year rupture risk for AAA >7cm> 7\,cm: >80%> 80\%.
    • Preferred screening modality: Abdominal ultrasound (UTZ).
  • Aortic Dissection:
    • Condition characterized by an intimal tear.
    • Stanford Classification: Type A (originates in ascending aorta), Type B (originates in descending aorta).
    • DeBakey Classification: Type 1 (involves whole aorta), Type 2 (involves up to aortic arch), Type 3 (involves up to descending thoracic aorta).
    • Type B3 involves up to the descending thoracic aorta.
    • Major complication: Pseudoaneurysm.
  • Blood Pressure Measurement: Target SBP inflation level is increased by 30mmHg30\,mmHg above palpated loss of pulse.

Hypertension Mechanisms & Management

  • Mechanisms of Hypertension:

Mechanisms of HTN Table

  • Intravascular volume: Pressure-natriuresis impairment leading to NaCl imbalance and volume expansion.
  • Autonomic Nervous System (ANS): Increased sympathetic outflow and decreased baroreceptor activity reset to higher pressure.
  • RAAS: Increased renin and angiotensin II, decreased AT1AT_1 activity, increased aldosterone.
  • Vascular mechanism: Increased NHE activity, impaired endothelium-dependent vasodilation, increased stiffness, decreased lumen, and increased SVR.
    • BP Targets & Thresholds: Target BP is generally <130/80mmHg< 130/80\,mmHg. Ambulatory thresholds follow the CAN mnemonic: Conventional (140/90mmHg140/90\,mmHg), Average (130/80mmHg130/80\,mmHg), Nighttime (120/70mmHg120/70\,mmHg).
    • First-Line Anti-hypertensive Therapy: ACE inhibitors (perindopril), ARBs (losartan), Calcium-channel blockers (CCBs), Thiazide diuretics.
  • Beta-blockers (bisoprolol), loop diuretics (furosemide), and alpha-1 blockers (terazosin) are NOT first-line.
    • Beta-Blocker Classification: Drug names starting with letters A through N are β1\beta_1-selective; O onwards are non-selective. Suffixes -ilol or -alol indicate mixed α/β\alpha/\beta blockers (e.g., carvedilol).

Pulmonary Embolism & Deep Vein Thrombosis

  • Clinical Symptoms: Lower calf cramp ("Charley horse") is the most common symptom of DVT; unexplained breathlessness is the most common symptom of PE.
  • Homan Sign: Discomfort behind the knee on forced foot dorsiflexion; lacks sensitivity and specificity for DVT.
  • PE Pathophysiology: Most common gas exchange abnormalities are arterial hypoxemia and increased alveolar-arterial O2O_2 tension gradient. Also causes increased pulmonary vascular resistance and alveolar hyperventilation.
  • Diagnostic Findings:
    • ECG: S1Q3T3S_1Q_3T_3 pattern (SS wave in lead I, QQ wave in lead III, inverted TT wave in lead III) alongside sinus tachycardia.
    • Chest X-ray: Hampton sign (triangular wedge-shaped opacity).
    • Biomarkers & Imaging: D-dimer upper limit = 500ng/mL500\,ng/mL. Venous ultrasonography is the principal imaging modality for DVT.
  • PE Risk Classification: Low-risk PE presents with normotension without RV dysfunction (6575%65\text{--}75\% of cases). Submassive PE features normotension with RV dysfunction (2025%20\text{--}25\% of cases).

Ischemic Heart Disease & Acute Coronary Syndromes

  • Clinical Examination:
    • Levine sign: Patient places a clenched fist over the sternum and leans forward during chest pain.
    • Atherosclerosis signs: Xanthelasmas and xanthomas.
    • Hypertensive changes: Fundoscopic examination showing increased light reflex and arteriovenous (AV) nicking.
    • Palpation/Auscultation: LV dyskinesia on palpation; apical systolic murmur of mitral regurgitation on auscultation.
  • Myocardial Oxygen Determinants:
    • Oxygen Demand: Heart rate, myocardial contractility, myocardial wall tension (preload, afterload, ventricular size).
    • Oxygen Supply: Blood oxygen-carrying capacity (inspired O2O_2, hemoglobin, pulmonary function) and coronary blood flow (vessel diameter, patency, vascular resistance, perfusion pressure, diastolic filling time).
  • Functional Classification: NYHA Class I represents patients who are asymptomatic during ordinary activity (able to walk >4> 4 blocks or climb >3> 3 flights of stairs).
  • Acute Management & STEMI Criteria:
    • Initial anti-ischemic drugs: Sublingual isosorbide dinitrate and beta-blockers.
    • Coronary Anatomy: Inferior wall MI involves the Right Coronary Artery (RCA).
    • Revascularization Target Times: Door-to-needle time (thrombolysis) 30mins\le 30\,mins; Door-to-balloon time (PCI) 90mins\le 90\,mins. Exact lesion dimensions are required prior to revascularization.

STEMI ECG Criteria

  • STEMI ECG Criteria: New ST-elevation at J-point in 2\ge 2 contiguous leads: 0.1mV\ge 0.1\,mV (1mm1\,mm) in all leads except V2V3V_2\text{--}V_3. In leads V2V3V_2\text{--}V_3: 0.2mV\ge 0.2\,mV in men 40\ge 40 years, 0.25mV\ge 0.25\,mV in men <40< 40 years, and 0.15mV\ge 0.15\,mV in women.

Heart Failure, Cardiomyopathies & Peripheral Vascular Disease

  • Heart Failure Pathophysiology & Management:
    • High-Output Heart Failure (HOHF): Results from persistent tachycardia or hypermetabolic conditions (e.g., thyrotoxicosis, chronic lung disease, aging); hypertension does not cause HOHF.
    • Ventricular Remodeling: Post-injury changes in LV mass, volume, and shape; includes both concentric and eccentric hypertrophy.
    • Endogenous Counter-regulatory Hormones: ANP and PGE2PGE_2 oppose RAAS and SNS activation.
    • Electrolyte Abnormalities in MI: Common changes include hypomagnesemia, hyponatremia, hypercalcemia, and hypophosphatemia.
    • GDMT Four First-Line Classes: ARNIs/ARBs, MRAs (spironolactone), SGLT2 inhibitors (dapagliflozin), and proven mortality-benefit beta-blockers (bisoprolol, carvedilol, metoprolol succinate). Metoprolol tartrate does NOT carry proven mortality benefit in HF.
  • Peripheral Vascular Disease & Cardiomyopathies:
    • Severe Raynaud Phenomenon: First-line medical therapy is a dihydropyridine CCB (nifedipine). Beta-blockers and non-DHP CCBs (diltiazem) are avoided.
    • Peripheral Artery Disease (PAD): Calf claudication indicates femoral-popliteal involvement. Skin moisturization is a key supportive measure.
    • Restrictive Cardiomyopathy: Most common cause is infiltrative disease (specifically amyloidosis, which most commonly presents as heart failure).
    • Dilated Cardiomyopathy: Characterized by EF <50%< 50\%; endomyocardial biopsy provides definitive diagnosis.
    • Peripartum Cardiomyopathy: Occurs in the 3rd3rd trimester up to 22 weeks post-delivery; diagnosis is invalid if HF presents early in pregnancy.
    • Hypertrophic Cardiomyopathy (HOCM): Risk of sudden cardiac death is driven by LV systolic dysfunction; physical examination shows pulsus bisferiens.

Congenital, Valvular & Pericardial Diseases

  • Physical Examination Findings: Right Ventricular Heave is assessed by placing the heel of the hand on the left parasternal border.
  • Congenital Heart Disease (CHD) Associations:
    • Down Syndrome: Atrioventricular (AV) canal defect / primum ASD.
    • DiGeorge Syndrome: Conotruncal anomalies.
    • Williams Syndrome: Supravalvular aortic stenosis.
    • Noonan Syndrome: Dysplastic pulmonary valve.
  • Atrial Septal Defects & Shunts:
    • Secundum ASD: Associated with Patent Foramen Ovale (PFO) and fixed split S_2$.\n * Primum ASD: Associated with cleft mitral valve and AV abnormalities.\n * Sinus Venosus ASD: Associated with PAPVR and Scimitar sign.\n * Patent Ductus Arteriosus (PDA): Continuous murmur best heard below the left clavicle causing LA and LV enlargement. Most common shunt is VSD.\n* Pericardial Disease:\n * Cardiac Tamponade: Characterized by Pulsus Paradoxus. Hemodynamically compromised patients require urgent pericardiocentesis.\n * Acute Pericarditis: Diagnostic criteria include chest pain, pericardial friction rub, and diffuse concave ST-elevation with PR depression (in contrast to convex ST-elevation in MI). Elevated CRP is supportive but not a primary diagnostic criterion. Colchicine reduces recurrence rates. Viral infection is the most common cause in developed countries.\n* Valvular Heart Disease:\n * Pulmonic Stenosis (PS): Produces right-sided findings exclusively (RVH, RAE, RAD, RBBB). Murmur does not decrease during squatting.\n * Mitral Stenosis (MS): Displays "hockey stick" and "fish mouth" appearance on echocardiogram; antiplatelets (aspirin/clopidogrel) are not part of treatment.\n * Aortic Stenosis (AS): 70yearoldwithcrescendodecrescendosystolicmurmuratright-year-old with crescendo-decrescendo systolic murmur at right2nd ICS is most commonly due to calcific degenerative etiology, leading to LV and ascending aorta enlargement.\n * Tricuspid Regurgitation (TR): Systolic murmur with Carvallo sign (intensifies on inspiration).\n * Pulmonic Regurgitation (PR): Diastolic Graham-Steell murmur heard at the left lower sternal border (intensifies on inspiration).\n * Tricuspid Stenosis (TS): Defined as severe if valve area is \le 1\,cm^2orpressurehalftimeisor pressure half-time is\ge 190\,ms$$.